REASONS FOR FAILURE OF MOPP TO CURE HODGKINS-DISEASE - THE IMPORTANCE OF DOSE AND SCHEDULE

被引：16
作者：
ARMITAGE, JO
CORDER, MP
机构：
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1982年 / 5卷 / 03期
关键词：
D O I：
10.1097/00000421-198206000-00014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：315 / 319
页数：5
相关论文
共 7 条
[1]  
CASE DC, 1976, CANCER TREAT REP, V60, P1217
[2]   CURABILITY OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY [J].
DEVITA, VT ;
SIMON, RM ;
HUBBARD, SM ;
YOUNG, RC ;
BERARD, CW ;
MOXLEY, JH ;
FREI, E ;
CARBONE, PP ;
CANELLOS, GP .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :587-595
[3]  
DEVITA VT, 1970, ANN INTERN MED, V73, P891
[4]   MEASUREMENT OF DRUG-DOSAGE INTENSITY IN MVPP THERAPY IN HODGKINS-DISEASE [J].
GREEN, JA ;
DAWSON, AA ;
FELL, LF ;
MURRAY, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (05) :511-514
[5]  
SANTORO A, 1980, P AM ASSOC CANC RES, V21, P470
[6]   DELAYED-HYPERSENSITIVITY IN HODGKINS-DISEASE - STUDY OF 103 UNTREATED PATIENTS [J].
YOUNG, RC ;
DEVITA, VT ;
CORDER, MP ;
HAYNES, HA .
AMERICAN JOURNAL OF MEDICINE, 1972, 52 (01) :63-&
[7]   IMMUNE ALTERATIONS IN HODGKINS-DISEASE - EFFECT OF DELAYED-HYPERSENSITIVITY AND LYMPHOCYTE TRANSFORMATION ON COURSE AND SURVIVAL [J].
YOUNG, RC ;
CORDER, MP ;
BERARD, CW ;
DEVITA, VT .
ARCHIVES OF INTERNAL MEDICINE, 1973, 131 (03) :446-454
1